G01N 2333/575
Hormones
G01N2333/575 (Hormones) appears on 1,055 US grants and 1,642 published applications in this corpus.
Search patents in G01N- Granted patents
- 1,055
- Published applications
- 1,642
- Assignees
- 791
- Inventors
- 3,164
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 5 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 6 | 0 |
| 1996 | 12 | 0 |
| 1997 | 37 | 0 |
| 1998 | 58 | 0 |
| 1999 | 29 | 0 |
| 2000 | 24 | 0 |
| 2001 | 17 | 3 |
| 2002 | 23 | 15 |
| 2003 | 15 | 56 |
| 2004 | 17 | 39 |
| 2005 | 14 | 56 |
| 2006 | 18 | 50 |
| 2007 | 14 | 42 |
| 2008 | 18 | 52 |
| 2009 | 22 | 50 |
| 2010 | 33 | 69 |
| 2011 | 37 | 84 |
| 2012 | 31 | 74 |
| 2013 | 43 | 62 |
| 2014 | 46 | 64 |
| 2015 | 42 | 93 |
| 2016 | 36 | 101 |
| 2017 | 54 | 92 |
| 2018 | 45 | 70 |
| 2019 | 48 | 83 |
| 2020 | 57 | 79 |
| 2021 | 53 | 90 |
| 2022 | 42 | 60 |
| 2023 | 35 | 50 |
| 2024 | 46 | 69 |
| 2025 | 31 | 80 |
| 2026 | 27 | 59 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- G01N 2333/62InsulinsIndexing code249
- G01N 2333/58Atrial natriuretic factor complexIndexing code158
- G01N 2333/59Follicle-stimulating hormone [fsh]Indexing code134
- G01N 2333/65Insulin-like growth factorsIndexing code88
- G01N 2333/61Growth hormones [gh]Indexing code59
- G01N 2333/585CalcitoninsIndexing code53
- G01N 2333/605GlucagonsIndexing code43
- G01N 2333/595GastrinsIndexing code29
All 24 subgroupsShow fewer
- G01N 2333/635Parathyroid hormoneIndexing code28
- G01N 2333/5754Endothelin, vasoactive intestinal contractor [vic]Indexing code25
- G01N 2333/5757Vasoactive intestinal peptide [vip] or related peptidesIndexing code19
- G01N 2333/5751Corticotropin releasing factor [crf]Indexing code16
- G01N 2333/5753Calcitonin gene related peptideIndexing code14
- G01N 2333/60Growth-hormone releasing factorsIndexing code14
- G01N 2333/5756ProlactinIndexing code12
- G01N 2333/655SomatostatinsIndexing code12
- G01N 2333/5755Neuropeptide yIndexing code11
- G01N 2333/5758Gastrin releasing peptideIndexing code11
- G01N 2333/645SecretinsIndexing code9
- G01N 2333/64RelaxinsIndexing code6
- G01N 2333/66ThymopoietinsIndexing code5
- G01N 2333/5759Thymosin or related peptidesIndexing code3
- G01N 2333/5752Placental lactogenIndexing code1
- G01N 2333/63MotilinsIndexing code0
Recent patents
- Nucleic acids encoding humanized anti-PACAP antibodies29 Sep 2026US 12,747,291 B2H. Lundbeck A.S.
- Compositions and methods for treating heart failure18 Aug 2026US 12,708,658 B2Zensun (Shanghai) Science & Technology, Co., Ltd.
- Parathyroid hormone receptor 1(PTH1R) antibodies and uses thereof4 Aug 2026US 12,698,346 B2Xoma (US) LLC
- Heart failure marker4 Aug 2026US 12,699,104 B2National University Corporation Kagawa University
- Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases28 Jul 2026US 12,693,221 B2Hycor Biomedical, Inc.
- Methods of determining glucose hypometabolism-induced energy crisis and treatments thereof8 Oct 2026US 2026/0306018 A1Senovia Biosciences LLC
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- Compositions and methods for treating diseases and conditions associated with activation of the nlrp3 inflammasome1 Oct 2026US 2026/0297180 A1
- Engineered antibody fusion proteins with modulable binding constants and their applications1 Oct 2026US 2026/0297181 A1The University of North Carolina at Chapel Hill
- Multi-Analyte Rapid Diagnostic Test for Sepsis Using Novel Biomarkers and Quantum Dot Technology1 Oct 2026US 2026/0298921 A1Trimar Domestic Inc.
Most cited
By later US patents
- Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants660US 5,750,373 AGenentech, Inc. · 1998
- Monovalent phage display562US 5,821,047 AGenentech, Inc. · 1998
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Systematic evolution of ligands by exponential enrichment: chimeric selex281US 5,637,459 ANeXstar Pharmaceuticals, Inc. · 1997